Business Context and Reporting Period
Inotiv, Inc. (NOTV) filed a Form 8-K on September 13, 2024, reporting the entry into material definitive agreements to restructure its capital. The company, incorporated in Indiana, operates in the preclinical research services sector. The reporting period focuses on the closing of transactions on September 13, 2024.
Key Financial Metrics and Capital Structure
- New Debt Issuance: Issued $22.6 million aggregate principal amount of 15.00% Senior Secured Second Lien PIK Notes due 2027 (comprising $22.0 million to investors and $0.6 million to the structuring agent).
- Cash Proceeds: Received $17.0 million in cash from the sale of the Second Lien Notes.
- Debt Extinguishment: Cancelled approximately $8.3 million of existing 3.25% Convertible Senior Notes due 2027 as partial consideration for the new notes.
- Remaining Convertible Debt: Approximately $131.7 million of the 3.25% Convertible Senior Notes remains outstanding.
- Equity Dilution: Issued warrants to purchase 3,946,250 shares of common stock to investors and 200,000 shares to the structuring agent. The exercise price is $1.57 per share.
- Interest Terms: The new Second Lien Notes accrue interest at 15.00% per annum, payable in kind (PIK) quarterly, with the first payment due December 31, 2024.
Material Changes and Covenant Adjustments
The company executed a Seventh Amendment to its Credit Agreement to facilitate the new financing. Key changes include:
- Covenant Waivers: Existing financial covenants are waived from the amendment date until June 30, 2025.
- New Covenants: New financial covenant tests will apply starting June 30, 2025. The amendment adds a maximum capital expenditure limit and a minimum EBITDA test.
- Restrictions: Reinvestment of funds from extraordinary receipts and asset sales is capped at $5.0 million in the aggregate.
- Governance: Lenders have the right to elect a non-voting third-party observer to the Board of Directors.
- Collateral: The Second Lien Notes are secured by a second lien security interest in substantially all of the company's and its subsidiaries' assets.
Outlook, Risks, and Contingencies
Redemption Terms: The Second Lien Notes are redeemable at the company's option prior to March 13, 2026, at 100% of principal plus accrued interest and a make-whole premium. Between March 14, 2026, and September 13, 2026, the redemption price is 102% of principal. After September 14, 2026, the redemption price is 100% of principal.
Events of Default: The Indenture includes standard events of default, including payment defaults (with a 30-day cure period for interest), defaults on other indebtedness exceeding $8.625 million (during the Amendment Relief Period) or $17.25 million (thereafter), and bankruptcy events. A bankruptcy event triggers immediate acceleration of all Second Lien Notes.
Registration Rights: The company must file a registration statement for the resale of shares underlying the warrants within 30 business days of the closing date and use commercially reasonable efforts to have it declared effective within 120 days.
Investor Verification Checklist
- Verify the exact remaining principal balance of the 3.25% Convertible Senior Notes ($131.7 million) and the terms of the remaining indenture.
- Review the specific definitions of the new "Fixed Charge Coverage Ratio" and "Secured Leverage Ratio" in the Seventh Amendment to the Credit Agreement.
- Assess the impact of the 15.00% PIK interest rate on future cash flow and net income, noting that interest is accrued rather than paid in cash initially.
- Confirm the timeline for the filing and effectiveness of the registration statement for the warrant shares.
- Monitor the company's ability to meet the new minimum EBITDA test and capital expenditure limits effective June 30, 2025.